A Study of whether Jatamansi (Nordostachys jatamansi DC) fant along with conventional treatment is more effective in managing post COVID anxiety than conventional method alone.

A Randomised Controlled Clinical Trial Of Add on Effect OF Jatamansi (Nardostachys Jatamansi DC) Fant With Conventional Post COVID Protocol in Post COVID Anxiety

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/050096

Enrollment

Registered

2023-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F418- Other specified anxiety disorders

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Post covid patients of Mild and Moderate anxiety of age group 16-80 yrs. will be selected irrespective of their gender and religion. 2. As per clinical examination and specific anxiety disorder scale post covid patients fulfilling the criteria of Mild and Moderate anxiety will be selected. 3. Patients willing to give consent to participate in the trial.

Exclusion criteria

Exclusion criteria: 1. Patients with known case of serious illness such as cancer, kidney disease, heart disease. 2. Patients with known case of Mental retardation or having any other psychological disorder.

Design outcomes

Primary

Measure	Time frame
Add on effect of Jatamansi (Nardostachys jatamansi DC) fant is more effective than conventional post covid protocol in management of post covid anxiety when tested with Hamiltons anxiety scale (HAM-A)Timepoint: 4 weeks	—

Secondary

Measure	Time frame
Jatamansi (Nordostachys jatamansi) Fant improves Kanti, medha of patientsTimepoint: Follow up on 7th, 14th, 21th and 28th day	—

Countries

India

Contacts

Public ContactDr Asmita Jadhav

Tilak Ayurved Mahavidyalaya Pune

asmita.niramaya@gmail.com9922437678

Outcome results